Patents by Inventor Gerard T. Hardiman

Gerard T. Hardiman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for blocking binding of CX3C chemokines using CX3C chemokine antibodies
    Patent number: 8343492
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: April 23, 2012
    Date of Patent: January 1, 2013
    Assignee: Schering Corporation
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, J. Fernando Bazan, Thomas J. Schall, Albert Zlotnik
  • MAMMALIAN CX3C CHEMOKINE ANTIBODIES
    Publication number: 20120225482
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Application
    Filed: April 23, 2012
    Publication date: September 6, 2012
    Applicant: Schering Corporation
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, Bazan Fernando J., Thomas P. Schall, Albert Zlotnik
  • Mouse CX3C chemokine polypeptides
    Patent number: 8173117
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: May 8, 2012
    Assignee: Schering Corporation
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B Bacon, Bazan Fernando J., Thomas P. Schall, Albert Zlotnik
  • MAMMALIAN CX3C CHEMOKINE ANTIBODIES
    Publication number: 20110189123
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Application
    Filed: July 9, 2010
    Publication date: August 4, 2011
    Applicant: SCHERING CORPORATION
    Inventors: GERARD T. HARDIMAN, DEVORA L. ROSSI, KEVIN B. BACON, BAZAN FERNANDO J., THOMAS J. SCHALL, ALBERT ZLOTNIK
  • HUMAN RECEPTOR PROTEINS; RELATED REAGENTS AND METHODS
    Publication number: 20100266599
    Abstract: Nucleic acids encoding mammalian Toll-like receptors (TLRs) have been identified in human cells. Recombinantly produced TLRs are used in the preparation of antibodies that are capable of binding to the TLRs. The antibodies are advantageously used in the prevention and treatment of septic shock, inflammatory conditions, and viral infections.
    Type: Application
    Filed: March 2, 2010
    Publication date: October 21, 2010
    Inventors: GERARD T. HARDIMAN, FERNANDO L. ROCK, J. FERNANDO BAZAN, ROBERT A. KASTELEIN, STEPHEN W.K. HO, YONG-JUN LIU
  • Mammalian CXC chemokine antibodies
    Patent number: 7785804
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: July 28, 2009
    Date of Patent: August 31, 2010
    Assignee: Schering Corporation
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, J. Fernando Bazan, Thomas J. Schall, Albert Zlotnik
  • Human DNAX toll-like receptor 4 proteins, related reagents and methods
    Patent number: 7670603
    Abstract: Nucleic acids encoding mammalian Toll-like receptors (TLRs) have been identified in human cells. Recombinantly produced TLRs are used in the preparation of antibodies that are capable of binding to the TLRs. The antibodies are advantageously used in the prevention and treatment of septic shock, inflammatory conditions, and viral infections.
    Type: Grant
    Filed: April 9, 2008
    Date of Patent: March 2, 2010
    Assignee: Schering Corporation
    Inventors: Gerard T. Hardiman, Fernando L. Rock, J. Fernando Bazan, Robert A. Kastelein, Stephen W. K. Ho, Yong-Jun Liu
  • MAMMALIAN CX3C CHEMOKINE ANTIBODIES
    Publication number: 20090317398
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Application
    Filed: July 28, 2009
    Publication date: December 24, 2009
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, Bazan Fernando J., Thomas P. Schall, Albert Zlotnik
  • Mammalian CXC chemokine antibodies
    Patent number: 7585502
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: August 26, 2008
    Date of Patent: September 8, 2009
    Assignee: Schering Corporation
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, J. Fernando Bazan, Thomas J. Schall, Albert Zlotnik
  • MAMMALIAN CX3C CHEMOKINE ANTIBODIES
    Publication number: 20090017032
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Application
    Filed: August 26, 2008
    Publication date: January 15, 2009
    Inventors: GERARD T. HARDIMAN, Devora L. Rossi, Kevin B. Bacon, J. Fernando Bazan, Thomas J. Schall, Albert Zlotnik
  • Methods of treating inflammation using mammalian CXC chemokine antibodies
    Patent number: 7431924
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: October 7, 2008
    Assignee: Schering Corporation
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin R. Bacon, Fernando J. Bazan, Thomas P. Schall, Albert Zlotnik
  • HUMAN RECEPTOR PROTEINS; RELATED REAGENTS AND METHODS
    Publication number: 20080199477
    Abstract: Nucleic acids encoding mammalian Toll-like receptors (TLRs) have been identified in human cells. Recombinantly produced TLRs are used in the preparation of antibodies that are capable of binding to the TLRs. The antibodies are advantageously used in the prevention and treatment of septic shock, inflammatory conditions, and viral infections.
    Type: Application
    Filed: April 9, 2008
    Publication date: August 21, 2008
    Inventors: Gerard T. Hardiman, Fernando L. Rock, J. Fernando Bazan, Robert A. Kastelein, Stephen W.K. Ho, Yong-Jun Liu
  • Human Receptor Proteins; Related Reagents and Methods
    Publication number: 20080194800
    Abstract: Nucleic acids encoding mammalian Toll-like receptors (TLRs) have been identified in human cells. Recombinantly produced TLRs are used in the preparation of antibodies that are capable of binding to the TLRs. The antibodies are advantageously used in the prevention and treatment of septic shock, inflammatory conditions, and viral infections.
    Type: Application
    Filed: April 9, 2008
    Publication date: August 14, 2008
    Inventors: Gerard T. Hardiman, Fernando L. Rock, J. Fernando Bazan, Robert A. Kastelein, Stephen W.K. Ho, Yong-Jun Liu
  • Human receptor proteins; related reagents and methods
    Patent number: 7271248
    Abstract: Nucleic acids encoding mammalian Toll-like receptors (TLRs) have been identified in human cells. Recombinantly produced TLRs are used in the preparation of antibodies that are capable of binding to the TLRs. The antibodies are advantageously used in the prevention and treatment of septic shock, inflammatory conditions, and viral infections.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: September 18, 2007
    Assignee: Schering Corporation
    Inventors: Gerard T. Hardiman, Fernando L. Rock, J. Fernando Bazan, Robert A. Kastelein, Stephen W. K. Ho, Yong-Jun Liu
  • Anti-mammalian CX3C cytokine antibodies
    Patent number: 7115379
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: March 25, 2003
    Date of Patent: October 3, 2006
    Assignee: Schering Corporation
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, Fernando J. Bazan, Thomas B. Schall, Albert Zlotnik
  • Mammalian CX3C chemokine
    Patent number: 6566503
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: January 25, 2001
    Date of Patent: May 20, 2003
    Assignee: Schering Corporation
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B Bacon, Bazan Fernando J., Thomas J. Schall, Albert Zlotnik
  • DNA encoding mammalian CX3C chemokine genes
    Patent number: 6548654
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: May 16, 1996
    Date of Patent: April 15, 2003
    Assignee: Schering Corporation
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, J. Fernando Bazan, Thomas J. Schall, Albert Zlotnik
  • Human receptor proteins; related reagents and methods
    Publication number: 20030032090
    Abstract: Nucleic acids encoding mammalian Toll-like receptors (TLRs) have been identified in human cells. Recombinantly produced TLRs are used in the preparation of antibodies that are capable of binding to the TLRs. The antibodies are advantageously used in the prevention and treatment of septic shock, inflammatory conditions, and viral infections.
    Type: Application
    Filed: September 10, 2001
    Publication date: February 13, 2003
    Applicant: Schering Corporation, a New Jersey Corporation
    Inventors: Gerard T. Hardiman, Fernando L. Rock, Bazan J. Fernando, Robert A. Kastelein, Stephen W.K. Ho, Yong-Jun Liu
  • Mammalian CX3C chemokine genes
    Publication number: 20030027990
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Application
    Filed: January 25, 2001
    Publication date: February 6, 2003
    Applicant: Schering Corporation, a New Jersey Corporation
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, Bazan Fernando J., Thomas P. Schall, Albert Zlotnik